76 related articles for article (PubMed ID: 8700529)
1. The brain specific Ras exchange factor CDC25 Mm: modulation of its activity through Gi-protein-mediated signals.
Zippel R; Orecchia S; Sturani E; Martegani E
Oncogene; 1996 Jun; 12(12):2697-703. PubMed ID: 8700529
[TBL] [Abstract][Full Text] [Related]
2. Differential response of the Ras exchange factor, Ras-GRF to tyrosine kinase and G protein mediated signals.
Shou C; Wurmser A; Suen KL; Barbacid M; Feig LA; Ling K
Oncogene; 1995 May; 10(10):1887-93. PubMed ID: 7761090
[TBL] [Abstract][Full Text] [Related]
3. Transformation suppressor activity of C3G is independent of its CDC25-homology domain.
Guerrero C; Fernandez-Medarde A; Rojas JM; Font de Mora J; Esteban LM; Santos E
Oncogene; 1998 Feb; 16(5):613-24. PubMed ID: 9482107
[TBL] [Abstract][Full Text] [Related]
4. The Ras Guanine nucleotide Exchange Factor CDC25Mm is present at the synaptic junction.
Sturani E; Abbondio A; Branduardi P; Ferrari C; Zippel R; Martegani E; Vanoni M; Denis-Donini S
Exp Cell Res; 1997 Aug; 235(1):117-23. PubMed ID: 9281359
[TBL] [Abstract][Full Text] [Related]
5. Calcium and calmodulin are essential for Ras-GRF1-mediated activation of the Ras pathway by lysophosphatidic acid.
Zippel R; Balestrini M; Lomazzi M; Sturani E
Exp Cell Res; 2000 Aug; 258(2):403-8. PubMed ID: 10896791
[TBL] [Abstract][Full Text] [Related]
6. Phosphorylation-dependent activation of the Ras-GRF/CDC25Mm exchange factor by muscarinic receptors and G-protein beta gamma subunits.
Mattingly RR; Macara IG
Nature; 1996 Jul; 382(6588):268-72. PubMed ID: 8717044
[TBL] [Abstract][Full Text] [Related]
7. Endogenous expression and protein kinase A-dependent phosphorylation of the guanine nucleotide exchange factor Ras-GRF1 in human embryonic kidney 293 cells.
Norum JH; Méthi T; Mattingly RR; Levy FO
FEBS J; 2005 May; 272(9):2304-16. PubMed ID: 15853814
[TBL] [Abstract][Full Text] [Related]
8. Ras-15A protein shares highly similar dominant-negative biological properties with Ras-17N and forms a stable, guanine-nucleotide resistant complex with CDC25 exchange factor.
Chen SY; Huff SY; Lai CC; Der CJ; Powers S
Oncogene; 1994 Sep; 9(9):2691-8. PubMed ID: 8058333
[TBL] [Abstract][Full Text] [Related]
9. PI 3-kinase gamma and protein kinase C-zeta mediate RAS-independent activation of MAP kinase by a Gi protein-coupled receptor.
Takeda H; Matozaki T; Takada T; Noguchi T; Yamao T; Tsuda M; Ochi F; Fukunaga K; Inagaki K; Kasuga M
EMBO J; 1999 Jan; 18(2):386-95. PubMed ID: 9889195
[TBL] [Abstract][Full Text] [Related]
10. The minimal active domain of the mouse ras exchange factor CDC25Mm.
Coccetti P; Mauri I; Alberghina L; Martegani E; Parmeggiani A
Biochem Biophys Res Commun; 1995 Jan; 206(1):253-9. PubMed ID: 7818528
[TBL] [Abstract][Full Text] [Related]
11. Mutations at position 1122 in the catalytic domain of the mouse ras-specific guanine nucleotide exchange factor CDC25Mm originate both loss-of-function and gain-of-function proteins.
Carrera V; Moroni A; Martegani E; Volponi C; Cool RH; Alberghina L; Vanoni M
FEBS Lett; 1998 Dec; 440(3):291-6. PubMed ID: 9872389
[TBL] [Abstract][Full Text] [Related]
12. A role for the Ras signalling pathway in synaptic transmission and long-term memory.
Brambilla R; Gnesutta N; Minichiello L; White G; Roylance AJ; Herron CE; Ramsey M; Wolfer DP; Cestari V; Rossi-Arnaud C; Grant SG; Chapman PF; Lipp HP; Sturani E; Klein R
Nature; 1997 Nov; 390(6657):281-6. PubMed ID: 9384379
[TBL] [Abstract][Full Text] [Related]
13. A dominant negative RAS-specific guanine nucleotide exchange factor reverses neoplastic phenotype in K-ras transformed mouse fibroblasts.
Bossù P; Vanoni M; Wanke V; Cesaroni MP; Tropea F; Melillo G; Asti C; Porzio S; Ruggiero P; Di Cioccio V; Maurizi G; Ciabini A; Alberghina L
Oncogene; 2000 Apr; 19(17):2147-54. PubMed ID: 10815806
[TBL] [Abstract][Full Text] [Related]
14. Expression of two different products of CDC25Mm, a mammalian Ras activator, during development of mouse brain.
Ferrari C; Zippel R; Martegani E; Gnesutta N; Carrera V; Sturani E
Exp Cell Res; 1994 Feb; 210(2):353-7. PubMed ID: 8299730
[TBL] [Abstract][Full Text] [Related]
15. Ras activation in response to lysophosphatidic acid requires a permissive input from the epidermal growth factor receptor.
Rubio I; Rennert K; Wittig U; Wetzker R
Biochem J; 2003 Dec; 376(Pt 3):571-6. PubMed ID: 14580235
[TBL] [Abstract][Full Text] [Related]
16. The platelet-derived-growth-factor receptor, not the epidermal-growth-factor receptor, is used by lysophosphatidic acid to activate p42/44 mitogen-activated protein kinase and to induce prostaglandin G/H synthase-2 in mesangial cells.
Goppelt-Struebe M; Fickel S; Reiser CO
Biochem J; 2000 Jan; 345 Pt 2(Pt 2):217-24. PubMed ID: 10620497
[TBL] [Abstract][Full Text] [Related]
17. Rit, a non-lipid-modified Ras-related protein, transforms NIH3T3 cells without activating the ERK, JNK, p38 MAPK or PI3K/Akt pathways.
Rusyn EV; Reynolds ER; Shao H; Grana TM; Chan TO; Andres DA; Cox AD
Oncogene; 2000 Sep; 19(41):4685-94. PubMed ID: 11032018
[TBL] [Abstract][Full Text] [Related]
18. Gi-mediated activation of the Ras/MAP kinase pathway involves a 100 kDa tyrosine-phosphorylated Grb2 SH3 binding protein, but not Src nor Shc.
Kranenburg O; Verlaan I; Hordijk PL; Moolenaar WH
EMBO J; 1997 Jun; 16(11):3097-105. PubMed ID: 9214627
[TBL] [Abstract][Full Text] [Related]
19. Extracellular signal-regulated activation of Rap1 fails to interfere in Ras effector signalling.
Zwartkruis FJ; Wolthuis RM; Nabben NM; Franke B; Bos JL
EMBO J; 1998 Oct; 17(20):5905-12. PubMed ID: 9774335
[TBL] [Abstract][Full Text] [Related]
20. Essential role for G proteins in prostate cancer cell growth and signaling.
Kue PF; Daaka Y
J Urol; 2000 Dec; 164(6):2162-7. PubMed ID: 11061948
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
